Mammography In Breast Cancer Screening – Current Knowledge, Challenges, The Impact of Artificial Intelligence, And Effectiveness With A Focus On Poland
DOI:
https://doi.org/10.12775/QS.2024.31.55967Keywords
breast cancer, mammography, AI, Screening, PolandAbstract
Mammography is a critical tool in breast cancer screening and secondary prevention, enabling early detection and significantly reducing breast cancer mortality. This literature review assesses the effectiveness of mammography in identifying early-stage tumors, discussing its advantages, limitations, and specific challenges. Additionally, advancements in imaging techniques, such as 3D tomosynthesis, are examined, especially for their enhanced sensitivity in women with dense breast tissue, which reduces structural overlap and improves diagnostic precision. The integration of artificial intelligence (AI) in mammographic image analysis opens new opportunities, supporting radiologists by automating the detection and classification of potential lesions, thereby increasing screening efficiency and reducing false-positive rates. However, effective implementation of AI requires seamless integration with clinical systems and ongoing research to refine algorithms for diverse clinical needs. Furthermore, legal frameworks are essential to delineate responsibility in AI-supported diagnostics. This review emphasizes the status of breast cancer screening in Poland, where participation rates remain low despite the availability of free screenings. This highlights the need for improved public awareness and accessibility, especially in underserved areas. Overall, the findings underscore the fundamental role of mammography in breast cancer detection, with AI and other technological advancements significantly enhancing diagnostic accuracy while identifying areas for further improvement.
References
Beata S, Anna ZN, Hanna R. Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers. 2022;14(10). doi:10.3390/cancers14102569
Breast Cancer Prevention Programs / Preventive Programs / Prevention with NFZ / For the Patient / National Health Fund – Lesser Poland Regional Branch. Accessed October 29, 2024. https://www.nfz-krakow.pl/dla-pacjenta/profiaktyka-/programy-profilaktyczne/programy-profilaktyki-raka-piersi/
Warner E. Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer. Cancers. 2018;10(12):477. doi:10.3390/cancers10120477
Szczeklik A, Gajewski P. Breast Cancer. Internal Medicine - A Concise Handbook. Accessed October 29, 2024. http://www.mp.pl/social/chapter/B01.X.G.1.
Wesołowska E. Mammary Gland. In: Radiology – Imaging Diagnostics: X-ray, CT, Ultrasound, and MRI. 3rd Edition. PZWL Medical Publishers; 2014:401-409.
Aristokli N, Polycarpou I, Themistocleous S, Sophocleous D, Mamais I. Comparison of the diagnostic performance of Magnetic Resonance Imaging (MRI), ultrasound and mammography for detection of breast cancer based on tumor type, breast density and patient’s history: A review. Radiography. 2022;28. doi:10.1016/j.radi.2022.01.006
Stephens M, Pradeep S, Khan A, Wynn M, Szczepura K, Mercer C. Skin tears in mammography: A narrative review. J Tissue Viability. 2023;32(4):577-584. doi:10.1016/j.jtv.2023.09.003
Strigel RM, Rollenhagen J, Burnside ES, et al. Screening Breast MRI Outcomes in Routine Clinical Practice: Comparison to BI-RADS Benchmarks. Acad Radiol. 2017;24(4):411-417. doi:10.1016/j.acra.2016.10.014
Vedantham S, Karellas A, Vijayaraghavan GR, Kopans DB. Digital Breast Tomosynthesis: State of the Art. Radiology. 2015;277(3):663-684. doi:10.1148/radiol.2015141303
Cserni G. Histological type and typing of breast carcinomas and the WHO classification changes over time. Pathologica. 2020;112(1):25. doi:10.32074/1591-951X-1-20
Tabár L, Dean PB, Tucker FL, et al. Breast cancers originating from the terminal ductal lobular units: In situ and invasive acinar adenocarcinoma of the breast, AAB. Eur J Radiol. 2022;152:110323. doi:10.1016/j.ejrad.2022.110323
Weaver O, Yang W. Imaging of Breast Cancers With Predilection for Nonmass Pattern of Growth: Invasive Lobular Carcinoma and DCIS—Does Imaging Capture It All? Am J Roentgenol. 2020;215(6):1504-1511. doi:10.2214/AJR.19.22027
Lilleborge M, Falk RS, Hovda T, Holmen MM, Ursin G, Hofvind S. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ. Acta Radiol Stockh Swed 1987. 2022;63(5):586-595. doi:10.1177/02841851211006319
Zielonke N, Kregting LM, Heijnsdijk EAM, et al. The potential of breast cancer screening in Europe. Int J Cancer. 2021;148(2):406-418. doi:10.1002/ijc.33204
Schiller-Fruehwirth I, Jahn B, Einzinger P, Zauner G, Urach C, Siebert U. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria. Value Health. 2017;20(8):1048-1057. doi:10.1016/j.jval.2017.04.009
Gupta G, Jamwal N, Gupta R. The Chiraiya project: a retrospective analysis of breast cancer detection gaps addressed via mobile mammography in Jammu Province, India. BMC Public Health. 2024;24(1):2087. doi:10.1186/s12889-024-19622-3
Jasiura A, Dera I, Szlachcic K, Gorzel M, Zmonarska J. Breast cancer screening programmes in selected European countries and Poland. J Educ Health Sport. 2021;11(7):11-21. doi:10.12775/34598
Rogalska A. Physical activity, screening cancer, and savings rate as indicators of health responsibility. J Educ Health Sport. 2024;69:55028. doi:10.12775/JEHS.2024.69.55028
Mrożek-Gąsiorowska M, Tambor M. How COVID-19 has changed the utilization of different health care services in Poland. BMC Health Serv Res. 2024;24(1):105. doi:10.1186/s12913-024-10554-7
Løberg M, Lousdal ML, Bretthauer M, Kalager M. Benefits and harms of mammography screening. Breast Cancer Res. 2015;17(1):63. doi:10.1186/s13058-015-0525-z
Grimm LJ, Avery CS, Hendrick E, Baker JA. Benefits and Risks of Mammography Screening in Women Ages 40 to 49 Years. J Prim Care Community Health. 2022;13:21501327211058322. doi:10.1177/21501327211058322
Hudson S. Beyond Breast Density - Novel Uses of Automated Mammographic Analysis in Breast Cancer Screening. London School of Hygiene & Tropical Medicine; 2024. doi:10.17037/PUBS.04672661
Yoon JH, Kim EK. Deep Learning-Based Artificial Intelligence for Mammography. Korean J Radiol. 2021;22(8):1225. doi:10.3348/kjr.2020.1210
Lamb LR, Lehman CD, Gastounioti A, Conant EF, Bahl M. Artificial Intelligence (AI) for Screening Mammography, From the AJR Special Series on AI Applications. Am J Roentgenol. 2022;219(3):369-380. doi:10.2214/AJR.21.27071
Lauritzen AD, Lillholm M, Lynge E, Nielsen M, Karssemeijer N, Vejborg I. Early Indicators of the Impact of Using AI in Mammography Screening for Breast Cancer. Moy L, ed. Radiology. 2024;311(3):e232479. doi:10.1148/radiol.232479
Högberg C, Larsson S, Lång K. Anticipating artificial intelligence in mammography screening: views of Swedish breast radiologists. BMJ Health Care Inform. 2023;30(1):e100712. doi:10.1136/bmjhci-2022-100712
Dang LA, Chazard E, Poncelet E, et al. Impact of artificial intelligence in breast cancer screening with mammography. Breast Cancer. 2022;29(6):967-977. doi:10.1007/s12282-022-01375-9
Ma S, Li Y, Yin J, et al. Prospective study of AI-assisted prediction of breast malignancies in physical health examinations: role of off-the-shelf AI software and comparison to radiologist performance. Front Oncol. 2024;14:1374278. doi:10.3389/fonc.2024.1374278
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Maciej Pachana, Marcin Piersiak, Hubert Sawczuk, Anna Tomasiewicz, Jan Zabierowski, Piotr Kukuła, Julia Marschollek, Maciej Ziomek

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 116
Number of citations: 0